BioRestorative Therapies, Inc. has announced a stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $2 million of its common stock until June 16, 2026.
Brown-Forman initiated a $400 million share buyback program in early October, but the program may not be an accretive use of capital. The company's growth outlook is concerning; secular trends in ...
On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...
Blue Foundry Bancorp Announces Adoption of Sixth Stock Repurchase Program for Up to 1,082,533 Shares
Blue Foundry Bancorp has announced its sixth stock repurchase program, authorizing the buyback of up to 1,082,533 shares of its common stock, representing about 5% of its outstanding shares. This ...
Lemonade (NYSE:LMND) said Monday it is in the process of renewing its reinsurance program, having decided to reduce the ceded proportion of its quota share reinsurance from ~55% to ~20%, effective ...
RESTON, Va., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Stride, Inc. (NYSE: LRN) (“Stride,” the “Company,” “we,” or “our”), one of the nation’s most ...
21d
Stock Market Today, March 23: Palantir Rises After the Pentagon Designates Maven Program of Record
Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial highlights potential expansion beyond defense into commercial applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results